SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-19-129368
Filing Date
2019-04-30
Accepted
2019-04-30 16:15:58
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d709639d10ka.htm 10-K/A 281508
2 EX-31.3 d709639dex313.htm EX-31.3 2949
3 EX-31.4 d709639dex314.htm EX-31.4 2791
  Complete submission text file 0001193125-19-129368.txt   288280
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35409 | Film No.: 19781936
SIC: 2834 Pharmaceutical Preparations